Abstract: Embodiments of the system support hospital operations, delivery of health care, and improve patient satisfaction. The interactive hospital information system utilizes inputs from a mobile device, eliminating the cost of fixed cameras and sensor systems in the hospital facility. Aspects of the invention facilitate real-time patient care and patient room updates by care providers, validating that prescribed devices, services, and setups are in place per protocol. The system communicates with rounding persons as to specific care management. Network devices, such as an iPad® or smartphone, are utilized to monitor and record ongoing activities in the healthcare setting.

Abstract: Embodiments of the system support hospital operations, delivery of health care, and improve patient satisfaction. The interactive hospital information system utilizes inputs from a mobile device, eliminating the cost of fixed cameras and sensor systems in the hospital facility. Aspects of the invention facilitate real-time patient care and patient room updates by care providers, validating that prescribed devices, services, and setups are in place per protocol. The system communicates with rounding persons as to specific care management. Network devices, such as an iPad® or smartphone, are utilized to monitor and record ongoing activities in the healthcare setting.

Abstract: This invention discloses methods of treating neovasculature diseases of the eye through the administration of a photosensitizing agent and subsequent exposure to light of specific wavelength sufficient to photoactivate the photosensitizing agent to occlude one or more vessels in the neovasculature for an extended period of time. Diseases treatable under this invention, include, for example: diabetic retinopathy; macular degeneration; subfoveal choroidal neovascularization, malignant uveal melanomas and other maladies of the human or animal eye or body.

Abstract: A method and system directs therapeutic light of a first wavelength to a patient's eye to excite a photosensitizing agent for PDT during a series of discrete periods of time that are separated by non-therapeutic intervals. Diagnostic light of a second wavelength can be directed to the eye during at least a portion of one or more of the non-therapeutic intervals to allow a physician to see the affect of the therapy.